Pinaverium May Provide Relief from Irritable Bowel Syndrome

Published On 2015-07-06 06:52 GMT   |   Update On 2023-10-13 06:34 GMT
Advertisement
A new study in Clinical Gastroenterology and Hepatology suggests that pinaverium may be a safe and effective treatment for Irritable Bowel Syndrome.

Pinaverium Bromide, an antispasmodic, is already in use in Europe, Canada and Mexico. But owing to the lack of original clinical studies, it is yet to be approved by the U.S. Food and Drug Administration (FDA).

Liang Zheng of the Nanjing University of Chinese Medicine who conducted this study says that his findings confirm the efficacy and effectiveness of
Advertisement
pinaverium
for IBS, which has no cure as of date. He concludes that pinaverium has the potential to become a viable first line drug for the treatment of IBS.

60 percent of the patients receiving pinaverium reported that their symptoms improved, as opposed to 34 percent in the control group. 29 percent of people receiving the drug reported no improvement while 11 percent felt that their symptoms had worsened.

There were no serious side effects recorded with pinaverium. 3.4% patients reported nausea, 3.2% from dizziness, 2.3% reported increase in blood pressure, while another 2.3% had abdominal discomfort.

IBS is a common chronic GI disorder that has high rates of recurrence.
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News